Gerald A. Soff

9.3k total citations · 2 hit papers
137 papers, 5.7k citations indexed

About

Gerald A. Soff is a scholar working on Hematology, Internal Medicine and Molecular Biology. According to data from OpenAlex, Gerald A. Soff has authored 137 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Hematology, 51 papers in Internal Medicine and 37 papers in Molecular Biology. Recurrent topics in Gerald A. Soff's work include Venous Thromboembolism Diagnosis and Management (51 papers), Platelet Disorders and Treatments (22 papers) and Blood Coagulation and Thrombosis Mechanisms (20 papers). Gerald A. Soff is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (51 papers), Platelet Disorders and Treatments (22 papers) and Blood Coagulation and Thrombosis Mechanisms (20 papers). Gerald A. Soff collaborates with scholars based in United States, United Kingdom and Canada. Gerald A. Soff's co-authors include Stephen Gately, Rekha Parameswaran, Thomas Lincoln, Trudy L. Cornwell, Simon Mantha, Jan J. Enghild, Hau C. Kwaan, M. Sharon Stack, Vikas P. Sukhatme and Helena J. Mauceri and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Gerald A. Soff

132 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Combined effects of angiostatin and ionizing radiation in antitumour therapy

1998 582 citations Gerald A. Soff et al. profile →
Role of direct oral anticoagulants in the treatment of cancer‐associated venous thromboembolism: guidance from the SSC of the ISTH

2018 299 citations Alok A. Khorana, Gerald A. Soff et al. Journal of Thrombosis and Haemostasis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerald A. Soff United States	41	2.1k	1.3k	1.3k	1.3k	1.1k	137	5.7k
Vijay V. Kakkar United Kingdom	37	1.6k 0.7×	1.3k 1.0×	1.3k 1.0×	541 0.4×	1.4k 1.3×	193	5.5k
Susanne Osanto Netherlands	37	1.9k 0.9×	940 0.7×	595 0.5×	757 0.6×	738 0.7×	95	5.1k
Ursula Rauch Germany	40	1.7k 0.8×	838 0.6×	1.9k 1.5×	602 0.5×	1.6k 1.4×	113	5.5k
Leo R. Zacharski United States	39	699 0.3×	1.2k 0.9×	1.8k 1.4×	637 0.5×	633 0.6×	141	4.6k
Gerald J. Roth United States	35	1.9k 0.9×	750 0.6×	2.3k 1.8×	340 0.3×	1.9k 1.6×	82	8.0k
Marek Z. Wojtukiewicz Poland	34	1.0k 0.5×	509 0.4×	996 0.8×	939 0.7×	240 0.2×	190	4.5k
Dick J. Richel Netherlands	43	3.5k 1.6×	750 0.6×	769 0.6×	2.2k 1.7×	662 0.6×	107	9.6k
Jan H. Verheijen Netherlands	48	1.5k 0.7×	269 0.2×	1.9k 1.5×	3.1k 2.4×	565 0.5×	110	5.9k
Joseph P. Miletich United States	37	784 0.4×	2.0k 1.5×	4.7k 3.7×	713 0.6×	1.8k 1.6×	59	7.2k
Michael Scully United Kingdom	28	675 0.3×	256 0.2×	948 0.7×	750 0.6×	405 0.4×	121	2.8k

Countries citing papers authored by Gerald A. Soff

Since Specialization

Citations

This map shows the geographic impact of Gerald A. Soff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald A. Soff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald A. Soff more than expected).

Fields of papers citing papers by Gerald A. Soff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald A. Soff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald A. Soff. The network helps show where Gerald A. Soff may publish in the future.

Co-authorship network of co-authors of Gerald A. Soff

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald A. Soff. A scholar is included among the top collaborators of Gerald A. Soff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald A. Soff. Gerald A. Soff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Borges, Giuliano Santos, et al.. (2026). Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia. New England Journal of Medicine. 394(11). 1061–1073.

Soff, Gerald A., et al.. (2024). Romiplostim in chemotherapy‐induced thrombocytopenia: A review of the literature. Cancer Medicine. 13(15). e7429–e7429. 5 indexed citations

Soff, Gerald A.. (2024). Cancer-Associated Thrombosis: Management of a Patient With an Isolated Calf Deep Vein Thrombosis. Journal of Clinical Oncology. 42(5). 494–499. 1 indexed citations

George, James N., et al.. (2022). Occult recurrent breast cancer masquerading as thrombotic thrombocytopenic purpura. American Journal of Hematology. 98(5). 830–832.

Armstrong, Katherine, Audrey Mauguen, Emily K. Slotkin, et al.. (2022). Chemotherapy‐induced thrombocytopenia in pediatric oncology: Scope of the problem and opportunities for intervention. Pediatric Blood & Cancer. 69(10). e29776–e29776. 3 indexed citations

Soff, Gerald A., Isabelle Ray‐Coquard, Jon P. Fryzek, et al.. (2022). Systematic literature review and meta-analysis on use of Thrombopoietic agents for chemotherapy-induced thrombocytopenia. PLoS ONE. 17(6). e0257673–e0257673. 11 indexed citations

Sanfilippo, Kristen M., Tzu‐Fei Wang, Marc Carrier, et al.. (2022). Standardization of risk prediction model reporting in cancer‐associated thrombosis: Communication from the ISTH SSC subcommittee on hemostasis and malignancy. Journal of Thrombosis and Haemostasis. 20(8). 1920–1927. 4 indexed citations

Scordo, Michael, Leah Gilbert, Jessica Flynn, et al.. (2022). Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantation. Blood Advances. 7(8). 1536–1544. 4 indexed citations

Wang, Tzu‐Fei, Kristen M. Sanfilippo, James D. Douketis, et al.. (2022). Peri‐procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 20(12). 3026–3038. 7 indexed citations

10.

Gilbert, Leah, et al.. (2022). Romiplostim for chemotherapy‐induced thrombocytopenia: Efficacy and safety of extended use. Research and Practice in Thrombosis and Haemostasis. 6(3). e12701–e12701. 10 indexed citations

11.

Mones, Jodi V., Michael B. Streiff, Alok A. Khorana, et al.. (2021). Rivaroxaban thromboprophylaxis for gastric/gastroesophageal junction tumors versus other tumors: A post hoc analysis of the randomized CASSINI trial. Research and Practice in Thrombosis and Haemostasis. 5(5). e12549–e12549. 9 indexed citations

12.

Dunbar, Andrew, Kelly L. Bolton, Sean M. Devlin, et al.. (2020). Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors. Blood. 137(15). 2103–2113. 66 indexed citations

13.

Bauersachs, Rupert, Alok A. Khorana, Agnes Lee, & Gerald A. Soff. (2020). Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban. Research and Practice in Thrombosis and Haemostasis. 4(4). 532–549. 8 indexed citations

14.

Wang, Tzu‐Fei, Henny H. Billett, Jean M. Connors, & Gerald A. Soff. (2020). Approach to Cancer-Associated Thrombosis: Challenging Situations and Knowledge Gaps. The Oncologist. 26(1). e17–e23. 12 indexed citations

15.

Soff, Gerald A.. (2018). Use of Direct Oral Anticoagulants for Treating Venous Thromboembolism in Patients With Cancer. Journal of the National Comprehensive Cancer Network. 16(5S). 670–673. 9 indexed citations

16.

Miao, Yimei, et al.. (2017). Efficacy and Thrombotic Adverse Events of Romiplostim Use in Patients with Thrombocytopenia Related to Underlying Malignancies. Blood. 130. 2324–2324. 3 indexed citations

17.

Mantha, Simon, Yimei Miao, Jonathan Wills, Rekha Parameswaran, & Gerald A. Soff. (2017). Enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study. Journal of Thrombosis and Thrombolysis. 43(4). 514–518. 58 indexed citations

18.

Soff, Gerald A., Yimei Miao, Sean M. Devlin, et al.. (2017). Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT). Results of a Phase 2 Trial. Blood. 130. 289–289. 5 indexed citations

19.

Giannarelli, Chiara, Matilde Alique, Dong Kwon Yang, et al.. (2014). Alternatively Spliced Tissue Factor Promotes Plaque Angiogenesis Through the Activation of Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor Signaling. Circulation. 130(15). 1274–1286. 42 indexed citations

20.

Rodgers, George M., Pamela S. Becker, Morey A. Blinder, et al.. (2012). Cancer- and Chemotherapy-Induced Anemia. Journal of the National Comprehensive Cancer Network. 10(5). 628–653. 171 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact